Given the contribution of Runx2 and downstream factors to osteosarcomagenesis and bone development, it is therefore consistent that elevated Runx2 expression has been correlated with significantly poorer outcomes in osteosarcoma [32]. The gene discussed is RUNX2; the disease is osteosarcoma.